☆ 4.6 Review

Oral Squamous Cell Carcinoma-Associated Thrombosis: What Evidence?

CANCERS (2022)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Article Medicine, General & Internal

Cancer-associated venous thromboembolism

Alok A. Khorana et al.

Summary: The association between cancer and increased coagulability leads to an elevated risk of venous thromboembolism, which is a severe complication for cancer patients and can result in poorer survival rates. Various cancer-specific mechanisms of thrombosis have been identified, and diagnosis requires clinical assessment and objective testing. Anticoagulant therapy is the cornerstone of treatment, and personalized treatment is important for improving quality of life.

NATURE REVIEWS DISEASE PRIMERS (2022)

添加到收藏夹

Review Oncology

Platelet and Cancer-Cell Interactions Modulate Cancer-Associated Thrombosis Risk in Different Cancer Types

Ana-Luisa Palacios-Acedo et al.

Summary: This study compares the interactions between cancer cells and platelets in three different cancer types with varying thrombotic risks: oral cancer (low risk), colorectal cancer (medium risk), and pancreatic cancer (high risk). Understanding these interactions is crucial for finding new biomarkers and therapeutic targets for cancer-associated thrombosis.

CANCERS (2022)

添加到收藏夹

Review Biochemistry & Molecular Biology

Venous Thromboembolism and Cancer: A Comprehensive Review from Pathophysiology to Novel Treatment

Mario Enrico Canonico et al.

Summary: Acute thrombotic events can reveal occult cancer in a significant number of cases. Malignancy interacts with the hemostatic system, leading to both thrombosis and bleeding. Cancer-related thrombotic events primarily affect the venous side and present in various conditions, including unusual sites of venous thrombosis. The selection of patients for anticoagulation management is complex, taking into account individual patient goals and preferences, prognosis of specific cancers, comorbidities, drug interactions, underweight states, and competing risks of morbidity and mortality. Anticoagulant treatment in cancer is widely debated, with direct oral anticoagulants showing efficacy and safety compared to traditional treatment.

BIOMOLECULES (2022)

添加到收藏夹

Review Hematology

Unanswered questions in cancer-associated thrombosis

Kristen M. Sanfilippo et al.

Summary: Cancer-associated VTE is a major cause of morbidity and mortality in cancer patients. Treatment of cancer-associated VTE requires considering the risk of anticoagulant-related bleeding and individualizing care based on patient factors. Available evidence suggests that direct oral anticoagulants are effective, ongoing anticoagulation is needed for patients with active cancer, and 'breakthrough' thrombotic events can be effectively treated.

BRITISH JOURNAL OF HAEMATOLOGY (2022)

添加到收藏夹

Review Oncology

Current trends of targeted therapy for oral squamous cell carcinoma

Hongjiao Li et al.

Summary: Oral squamous cell carcinoma (OSCC) is a malignant disease with a profound impact on human health and life quality. Traditional treatment methods have limitations, but nanotechnology and newly developed therapies offer hope for targeted therapy.

JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2022)

添加到收藏夹

Article Oncology

2022 international clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer, including patients with COVID-19

Dominique Farge et al.

LANCET ONCOLOGY (2022)

添加到收藏夹

Article Oncology

Therapeutic approaches for the treatment of head and neck squamous cell carcinoma-An update on clinical trials

Bharat Goel et al.

Summary: Head and neck squamous cell carcinoma (HNSCC) is a common non-skin cancer with smoking and high-risk human papillomavirus (HPV) infection being major risk factors. Combination therapy is considered the most effective treatment choice, but survival rates have not significantly improved. Immunotherapy and other targeted drugs are also being studied.

TRANSLATIONAL ONCOLOGY (2022)

添加到收藏夹

Review Oncology

The Emerging Impact of Tumor Budding in Oral Squamous Cell Carcinoma: Main Issues and Clinical Relevance of a New Prognostic Marker

Lucrezia Togni et al.

Summary: Tumor budding is an independent prognostic factor in various solid cancers, including oral squamous cell carcinoma. It can predict poor survival outcomes and has potential applications in daily pathological practice. However, further research and validation are needed due to the lack of standardized assessment methods.

CANCERS (2022)

添加到收藏夹

Review Hematology

Thrombotic complications in patients with cancer: Advances in pathogenesis, prevention, and treatment-A report from ICTHIC 2021

Anna Falanga et al.

Summary: This article discusses the pathogenesis, risk assessment, diagnosis, treatment, and prevention recommendations regarding thrombotic complications in cancer patients. The virtual 10th International Conference on Thrombosis & Hemostasis Issues in Cancer in April 2021 addressed various aspects of VTE in cancer patients, including emerging areas of interest like immunotherapy and genetic alterations.

RESEARCH AND PRACTICE IN THROMBOSIS AND HAEMOSTASIS (2022)

添加到收藏夹

Article Pathology

Update from the 5th Edition of the World Health Organization Classification of Head and Neck Tumors: Tumours of the Oral Cavity and Mobile Tongue

Susan Muller et al.

Summary: The fifth chapter of the 2022 World Health Organization Classification of Tumours of the Head and Neck has undergone modifications, including the addition of a new section on Non-neoplastic Lesions and the separation of the Oral potentially malignant disorders and Oral epithelial dysplasia section. Carcinoma cuniculatum and verrucous carcinoma are now described in dedicated sections. This review summarizes these changes and highlights their clinical, histological, and molecular significance.

HEAD & NECK PATHOLOGY (2022)

添加到收藏夹

Article Biochemistry & Molecular Biology

Oral Squamous Cell Carcinoma Is Associated with a Low Thrombosis Risk Due to Storage Pool Deficiency in Platelets

Pierre Haen et al.

Summary: Oral squamous cell carcinoma (OSCC) is associated with low systemic thrombosis risk despite having biological features of cancers with high thrombosis risk. Studies show that OSCC tumors have a high local thrombosis risk but a reduction in systemic thrombosis risk in tongue tumor mice, possibly due to reduced platelet reactivity and granule pool deficiency.

BIOMEDICINES (2021)

添加到收藏夹

Article Hematology

American Society of Hematology 2021 guidelines for management of venous thromboembolism: prevention and treatment in patients with cancer

Gary H. Lyman et al.

Summary: These evidence-based guidelines aim to support decision-making on the prevention and treatment of VTE in cancer patients, covering mechanical and pharmacological prophylaxis, as well as recommendations for initial, short-term, and long-term treatment based on patient risk and treatment circumstances. Recommendations vary depending on patient risk level and treatment situation.

BLOOD ADVANCES (2021)

添加到收藏夹

Review Medicine, General & Internal

Head and neck cancer

Mayur D. Mody et al.

Summary: Head and neck cancer is the seventh most common type of cancer worldwide, with the predominant risk factors being tobacco use, alcohol abuse, and oncogenic viruses. Treatment typically involves a multidisciplinary approach with surgery, radiotherapy, and systemic therapy, and is challenging due to site-specific and histology-specific variations.

LANCET (2021)

添加到收藏夹

Article Oncology

Venous Thromboembolism Prophylaxis and Treatment in Patients With Cancer: ASCO Clinical Practice Guideline Update

Nigel S. Key et al.

JOURNAL OF CLINICAL ONCOLOGY (2020)

添加到收藏夹

Review Biochemistry & Molecular Biology

Thrombosis Risk Associated with Head and Neck Cancer: A Review

Pierre Haen et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)

添加到收藏夹

Review Oncology

2019 international clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer

Dominique Farge et al.

LANCET ONCOLOGY (2019)

添加到收藏夹

Article Otorhinolaryngology

Intravenous 5-Fluorouracil in Patients With Advanced Squamous Cell Carcinoma: A Retrospective Study

Elvira Buxo et al.

ANNALS OF OTOLOGY RHINOLOGY AND LARYNGOLOGY (2018)

添加到收藏夹

Article Oncology

Comparison of an Oral Factor Xa Inhibitor With Low Molecular Weight Heparin in Patients With Cancer With Venous Thromboembolism: Results of a Randomized Trial (SELECT-D)

Annie M. Young et al.

JOURNAL OF CLINICAL ONCOLOGY (2018)

添加到收藏夹

Article Hematology

Role of direct oral anticoagulants in the treatment of cancer-associated venous thromboembolism: guidance from the SSC of the ISTH

A. A. Khorana et al.

JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2018)

添加到收藏夹

Article Medicine, General & Internal

Edoxaban for the Treatment of Cancer-Associated Venous Thromboembolism

Gary E. Raskob et al.

NEW ENGLAND JOURNAL OF MEDICINE (2018)

添加到收藏夹

Review Otorhinolaryngology

Antithrombotic Therapy for Venous Thromboembolism and Prevention of Thrombosis in Otolaryngology-Head and Neck Surgery: State of the Art Review

John D. Cramer et al.

OTOLARYNGOLOGY-HEAD AND NECK SURGERY (2018)

添加到收藏夹

Article Hematology

Apixaban versus Dalteparin for the Treatment of Acute Venous Thromboembolism in Patients with Cancer: The Caravaggio Study

Giancarlo Agnelli et al.

THROMBOSIS AND HAEMOSTASIS (2018)

添加到收藏夹

Review Oncology

Cancer-Associated Thrombosis: An Overview of Mechanisms, Risk Factors, and Treatment

Norbaini Binti Abdol Razak et al.

CANCERS (2018)

添加到收藏夹

Article Oncology

Cetuximab-Carboplatin-5-Fluorouracil Regimen in Elderly Patients with Recurrent or Metastatic Head and Neck Squamous-Cell Carcinoma: A French Retrospective Survey

Mickael Burgy et al.

ONCOLOGY (2017)

添加到收藏夹

Article Oncology

Rapid occurrence of left ventricular thrombus associated with platinum-based chemotherapy plus cetuximab for the treatment of metastatic squamous cell carcinoma of the head and neck: A case report

Atsushi Ikeda et al.

MOLECULAR AND CLINICAL ONCOLOGY (2017)

添加到收藏夹

Article Oncology

Urokinase-type plasminogen activator receptor (uPAR), tissue factor (TF) and epidermal growth factor receptor (EGFR): tumor expression patterns and prognostic value in oral cancer

Anders Christensen et al.

BMC CANCER (2017)

添加到收藏夹

Article Hematology

Cancer microvesicles induce tissue factor-related procoagulant activity in endothelial cells in vitro

Mufuliat Adeola Adesanya et al.

BLOOD COAGULATION & FIBRINOLYSIS (2017)

添加到收藏夹

Article Dentistry, Oral Surgery & Medicine

Elevated Level of Circulating Platelet-derived Microparticles in Oral Cancer

J. G. Ren et al.

JOURNAL OF DENTAL RESEARCH (2016)

添加到收藏夹

Article Otorhinolaryngology

Pre-treatment clinical assessment in head and neck cancer: United Kingdom National Multidisciplinary Guidelines

A. Robson et al.

JOURNAL OF LARYNGOLOGY AND OTOLOGY (2016)

添加到收藏夹

Article Dentistry, Oral Surgery & Medicine

Incidence of Venous Thromboembolism After Oral Oncologic Surgery With Simultaneous Reconstruction

Yasumasa Kakei et al.

JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY (2016)

添加到收藏夹

Review Peripheral Vascular Disease

Approach to chemotherapy-associated thrombosis

Peter Oppelt et al.

VASCULAR MEDICINE (2015)

添加到收藏夹

Review Hematology

Global assays of hemostasis in the diagnostics of hypercoagulation and evaluation of thrombosis risk

Elena N. Lipets et al.

THROMBOSIS JOURNAL (2015)

添加到收藏夹

Article Oncology

Incidence and predictors of venous thromboembolism (VTE) among ambulatory high-risk cancer patients undergoing chemotherapy in the United States

Alok A. Khorana et al.

CANCER (2013)

添加到收藏夹

Article Otorhinolaryngology

Venous thromboembolism in patients with head and neck cancer after surgery

Leo Thai et al.

HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK (2013)

添加到收藏夹

Article Immunology

Cancer cell-derived microparticles bearing P-selectin glycoprotein ligand 1 accelerate thrombus formation in vivo

Grace M. Thomas et al.

JOURNAL OF EXPERIMENTAL MEDICINE (2009)

添加到收藏夹

Article Hematology

Development and validation of a predictive model for chemotherapy-associated thrombosis

Alok A. Khorana et al.

BLOOD (2008)

添加到收藏夹

Article Medicine, General & Internal

Platinum-based chemotherapy plus cetuximab in head and neck cancer

Jan B. Vermorken et al.

NEW ENGLAND JOURNAL OF MEDICINE (2008)

添加到收藏夹

Article Dentistry, Oral Surgery & Medicine

Expression of vascular endothelial growth factor (VEGF) in normal oral mucosa, oral dysplasia and oral squamous cell carcinoma

S. Johnstone et al.

INTERNATIONAL JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY (2007)

添加到收藏夹

Letter Hematology

Thromboembolism is a leading cause of death in cancer patients receiving outpatient chemotherapy

A. A. Khorana et al.

JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2007)

添加到收藏夹

Article Oncology

Risk factors for chemotherapy-associated venous thromboembolism in a prospective observational study

AA Khorana et al.

CANCER (2005)

添加到收藏夹

Article Medicine, General & Internal

Cardiovascular risk factors and venous thromboembolism incidence - The longitudinal investigation of thromboembolism etiology

AW Tsai et al.

ARCHIVES OF INTERNAL MEDICINE (2002)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.